Alemtuzumab (Lemtrada) and Fosnetupitant and Palonosetron
Determining the interaction of Alemtuzumab (Lemtrada) and Fosnetupitant and Palonosetron and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: fosnetupitant / palonosetron
Brand name: Akynzeo for injection
Synonyms: Fosnetupitant and palonosetron (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab (Lemtrada)-Fosnetupitant and palonosetron injection
- Alemtuzumab (Lemtrada)-Fosnetupitant/palonosetron Intravenous
- Alemtuzumab (Lemtrada)-Fosphenytoin
- Alemtuzumab (Lemtrada)-Fosphenytoin Injection
- Alemtuzumab (Lemtrada)-Fosphenytoin Sodium
- Alemtuzumab (Lemtrada)-Fospropofol Intravenous
- Fosnetupitant and Palonosetron-Alemtuzumab Intravenous
- Fosnetupitant and Palonosetron-Alenaze-D
- Fosnetupitant and Palonosetron-Alendronate
- Fosnetupitant and Palonosetron-Alendronate and cholecalciferol
- Fosnetupitant and Palonosetron-Alendronate Effervescent Tablets
- Fosnetupitant and Palonosetron-Alendronate Oral Solution